Your browser doesn't support javascript.
loading
Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease.
Bachurin, Sergey O; Shevtsova, Elena F; Makhaeva, Galina F; Aksinenko, Alexey Yu; Grigoriev, Vladimir V; Goreva, Tatiana V; Epishina, Tatiana A; Kovaleva, Nadezhda V; Boltneva, Natalia P; Lushchekina, Sofya V; Rudakova, Elena V; Vinogradova, Darya V; Shevtsov, Pavel N; Pushkareva, Elena A; Dubova, Ludmila G; Serkova, Tatiana P; Veselov, Ivan M; Fisenko, Vladimir P; Richardson, Rudy J.
Affiliation
  • Bachurin SO; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Shevtsova EF; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Makhaeva GF; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Aksinenko AY; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Grigoriev VV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Goreva TV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Epishina TA; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Kovaleva NV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Boltneva NP; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Lushchekina SV; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia.
  • Rudakova EV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Vinogradova DV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Shevtsov PN; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Pushkareva EA; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Dubova LG; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Serkova TP; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Veselov IM; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 142432 Chernogolovka, Russia.
  • Fisenko VP; Department of Pharmacology, Institute of Biodesign and Complex System Modelling, Biomedical Science & Technology Park, Sechenov I.M. First Moscow State Medical University, 119991 Moscow, Russia.
  • Richardson RJ; Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Int J Mol Sci ; 23(22)2022 Nov 11.
Article in En | MEDLINE | ID: mdl-36430413
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurodegenerative Diseases / Alzheimer Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: RUSSIA Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurodegenerative Diseases / Alzheimer Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: RUSSIA Country of publication: Switzerland